ANDHealth extends CHICC partnership to support rapid growth in commercialisation of Victorian digital & connected health solutions
Posted: 6 August 2024 ANDHealth has today announced the extension of the Victorian Connected Health Innovation and Commercialisation Centre (CHICC) initiative for a further 12 months, off the back of the substantial growth in the local industry over…
Future Health Today And Torch Recruit – Changing The Course Of Chronic Disease
Posted: 6 August 2024 In Australia, accessing primary healthcare through general practitioners (GPs) is a cornerstone of the healthcare system. With more than four in five Australians visiting their GP annually and two million attending weekly, general practice…
AusBiotech appoints Rosanne Hyland Deputy CEO
Posted: 6 August 2024 Ms Rosanne Hyland has been appointed as Deputy Chief Executive Officer of AusBiotech, Australia’s peak association for the life sciences industry, after serving as Business Manager and Chief Operating Officer for five years. Over…
Major Development Milestone Delivered in Optiscan’s Telepathology Platform
Posted: 1 August 2024 Optiscan Imaging Limited (ASX:OIL) (‘Optiscan’ or ‘The Company’) is pleased to announce the successful completion of the beta phase of its innovative cloud-connected telepathology platform, developed in partnership with Prolucid Technologies. This development represents…
PAT-DX1 GMP manufacturing run update
Posted: 1 August 2024 Patrys Limited. a therapeutic antibody development company, provides the following update regarding the recently completed GMP manufacturing run of PAT-DX1. Patrys’ Contract Development Manufacturing Organization (CDMO) advised the Company that it has identified an…
Help shape the Department of Health’s national audit of the Health and Medical Research Workforce
Posted: 1 August 2024 The Department of Health and Aged Care is conducting a national audit of the Health and Medical Research Workforce, with the findings helping to inform the development of the National Health and Medical Research…
Babies offered peanut allergy treatment program under world-first national model
Posted: 31 July 2024 Babies with peanut allergies in Australia will be offered a treatment program under a world-first model aiming to transform allergy care. Ten paediatric hospitals across five states have partnered with the National Allergy Centre of…
MRFF funds new national centre for mRNA medicines
Posted: 31 July 2024 The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested $4 million into establishing Australia’s first National Centre for Biopharmaceutical Optimisation of mRNA Therapeutics (CORTx), being led by Monash University to optimise mRNA therapeutic…
Using mRNA technology to prevent cancer and treat disease
Posted: 31 July 2024 The Albanese Government is awarding more than $19 million to six research projects that use mRNA – the medical technology that underpins the Pfizer and Moderna COVID vaccines – to find vaccines to prevent…
Innovative technology shows promise toward hepatitis B treatment
Posted: 31 July 2024 Using cutting-edge CRISPR technology, researchers have successfully managed to reduce hepatitis B virus levels in the laboratory, lowering key viral markers by up to 96 per cent. This advancement paves the way for a…
Funding boosts endometriosis drug discovery efforts
Posted: 31 July 2024 A key receptor is being targeted using robotic high-throughput screening at the National Drug Discovery Centre (NDDC) to fast-track new treatments for endometriosis. Advancing endometriosis treatment research Endometriosis affects 10% of women of reproductive…
Telix Successfully Prices A$650 Million Convertible Bonds
Posted: 30 July 2024 Telix is pleased to announce that it has successfully priced A$650 million 2.375 per cent convertible notes due 2029. The convertible notes, also referred to as “convertible bonds” (Convertible Bonds), are convertible into fully…
